KEY FINDINGS
The Asia-Pacific advanced wound care management market is projected to develop with a CAGR of 12.34% over the forecasted years of 2021 to 2028. Key drivers like the growing number of laboratories with advanced medical facilities, the increased prevalence of chronic conditions, enhanced health awareness, and high disposable incomes are primarily attributed to the regional market’s growth.
MARKET INSIGHTS
The Asia-Pacific advanced wound care management market growth assessment entails the in-depth evaluation of South Korea, India, Vietnam, Thailand, the United Kingdom, China, Japan, Indonesia, and the rest of the Asia-Pacific. Advanced wound care constitutes a smaller segment of India’s wound care market, since traditional wound care holds a dominant share owing to the high costs associated with advanced care. The development in top-tier hospitals as well as health insurance is a key driver fueling the demand for advanced wound care products. However, government hospitals in India continue using conventional wound care on account of the high incentives offered by local firms to doctors. India is also observing an increase in high-end multi-specialty hospitals, catering to the demands of major consumers in advanced wound care.
Surgical site infections (SSIs) are among the most prevalent healthcare-associated infections (HAI), especially in lower-income countries. As per a study conducted in 2016, the rates of SSIs in Vietnam were significantly higher for 11 of the 26 types of surgical procedures, than for the United States Centers for Disease Control and Prevention’s National Healthcare Safety Network (CDC-NHSN). Furthermore, the substantial surge in healthcare expenditure is expected to augment the demand for advanced wound care. Hence, these factors are set to fuel the market growth in the Asia-Pacific over the forecast period.
COMPETITIVE INSIGHTS
Some of the top companies operating in the market are Johnson & Johnson, Smith & Nephew PLC, Medtronic PLC, B Braun Melsungen AG, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING AGING POPULATION
3.1.2. INCIDENCE OF CHRONIC DISEASES
3.1.3. ADVANCEMENT IN TECHNOLOGY
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF ADVANCED WOUND CARE PRODUCTS
3.2.2. LACK OF TRAINED PROFESSIONALS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON ADVANCED WOUND CARE MANAGEMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY PRODUCT
5.1. THERAPY DEVICES
5.2. EXUDATE MANAGEMENT
5.3. INFECTION MANAGEMENT
5.4. ACTIVE WOUND CARE
6. MARKET BY APPLICATION
6.1. CHRONIC WOUNDS
6.2. ACUTE WOUNDS
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. COMMUNITY HEALTH SERVICE CENTERS
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA-PACIFIC
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. CHINA
8.1.5.2. JAPAN
8.1.5.3. INDIA
8.1.5.4. AUSTRALIA & NEW ZEALAND
8.1.5.5. SOUTH KOREA
8.1.5.6. THAILAND
8.1.5.7. INDONESIA
8.1.5.8. VIETNAM
8.1.5.9. REST OF ASIA-PACIFIC
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. 3M COMPANY
9.2.2. B BRAUN MELSUNGEN AG
9.2.3. COLOPLAST
9.2.4. CONVATEC GROUP PLC
9.2.5. ESSITY AB
9.2.6. HARTMANN GROUP
9.2.7. HOLLISTER INCORPORATED
9.2.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9.2.9. JOHNSON & JOHNSON (ETHICON INC)
9.2.10. MEDTRONIC PLC
9.2.11. MEDLINE INDUSTRIES INC
9.2.12. MOLNLYCKE HEALTH CARE AB
9.2.13. ORGANOGENESIS HOLDINGS INC
9.2.14. SMITH & NEPHEW PLC
1. 3M COMPANY
2. B BRAUN MELSUNGEN AG
3. COLOPLAST
4. CONVATEC GROUP PLC
5. ESSITY AB
6. HARTMANN GROUP
7. HOLLISTER INCORPORATED
8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9. JOHNSON & JOHNSON (ETHICON INC)
10. MEDTRONIC PLC
11. MEDLINE INDUSTRIES INC
12. MOLNLYCKE HEALTH CARE AB
13. ORGANOGENESIS HOLDINGS INC
14. SMITH & NEPHEW PLC